about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesDevelopment of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in ChinaBurrowing through the Heterogeneity: Review of Mouse Models of PTCL-NOSTreatment of peripheral T-cell lymphoma: are we data driven or driving the data?A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas.Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.Characterization of a new mouse model for peripheral T cell lymphoma in humans.ALK-activating homologous mutations in LTK induce cellular transformation.Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapyTCR-dependent transformation of mature memory phenotype T cells in mice.Primary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations.Clinical analysis and prognostic significance of L-asparaginase containing multidrug chemotherapy regimen in incipient peripheral T-cell lymphoma.Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells.Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.HDAC inhibitor-based therapies and haematological malignancy.Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma.New targets of therapy in T-cell lymphomas.Peripheral T-cell lymphomas: a review of current approaches and hopes for the future.The potential of pralatrexate as a treatment of peripheral T-cell lymphoma.Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of OncogenesisUncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches.Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis.The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation.Peripheral T-cell lymphoma with left ankle swelling, ulceration and fever.Challenging perspectives on the cellular origins of lymphoma.Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy.Pathobiology of anaplastic large cell lymphoma.Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study.Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs.The Classification of Lymphoma: Updating the WHO Classification
P2860
Q24604581-1416920B-ACCE-499E-9298-7C23C0EE05E4Q28070073-0A412506-EB51-4563-A02D-7ABD77D2C706Q28076192-F99A080A-C3D0-43CC-A541-4E49FB212033Q30613674-9B5E907E-04E9-4E61-8E9C-EACC4D01AD1CQ33409982-57670BF4-711B-4018-99C0-B213D763F54BQ33423816-0B782C03-A05E-4F9B-8674-A1A280C3B719Q33839970-A938009D-DADC-4E70-973E-2DFA780A2D55Q34097906-0FD71F7A-8A7D-4E0C-80E4-0502CFA27D92Q34162940-6F589ECD-81C1-44B9-A890-5A03353D7275Q35207251-165B77E9-9E41-412E-9890-A15F890EBF85Q35369863-6371123E-C5E8-42B8-A440-A8AE7308FF0BQ35697053-E6BFE5CA-8A2B-4EDC-8F64-22DD7EE7CA4CQ35958818-E33FC7C9-A1F1-4E81-9EB5-92FE6DA98834Q37376200-45F55D61-5A42-480C-A4F8-D96168329C9EQ37391571-A48DC3BC-804B-436F-8FE6-3AA66444557BQ37514642-F8C07BEB-03F8-4DE2-A01C-F6365FE067EAQ37579991-DD6BAACD-544C-4BB4-BCDA-F6C10D0C86A5Q37701472-D731E695-1584-4196-AC3D-37B28849A2BFQ38113568-0D1120F8-3568-4DEF-AA87-9662EBCA32DDQ38198754-750BDC96-87A8-4A3F-83A7-99FFFE5ADDD7Q38257974-60A90566-6D92-45C5-ACAA-C169511D18E2Q38410415-14813252-516B-4B6F-9FC7-4B3E006CB3F0Q39608513-32EACA1E-BFF7-456C-AFC8-30C4CEF63AB4Q39836717-2759B661-66EA-41AA-83C1-00E2A6E4645BQ40127790-56B0CDD8-7B6B-4AA8-B525-DC7998D67813Q40523569-2F2FC5A7-7500-4D28-95F9-EBB9F53E9713Q41607082-D64EF405-6AEB-415C-A2A2-CEA222E55DCFQ41852473-25979A4F-B536-49D7-92BC-41954C283757Q41942675-122120F5-7321-4CAE-9B11-ED16F25F336FQ43765534-24BF570D-9034-4709-AC20-A9DAA1218848Q53294611-70AF223B-BA49-4E69-A872-1A644AB66995Q57279328-8931F0FC-8A1D-4F89-A7D6-EAD97AEEB892
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Peripheral T-cell lymphomas.
@en
type
label
Peripheral T-cell lymphomas.
@en
prefLabel
Peripheral T-cell lymphomas.
@en
P1433
P1476
Peripheral T-cell lymphomas.
@en
P2093
Kerry J Savage
P304
P356
10.1016/J.BLRE.2007.03.001
P577
2007-05-18T00:00:00Z